Tiano, H F <br/><br/>
Human CYP2A6 activation of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK): mutational specificity in the gpt gene of AS52 cells.  [electronic resource] 

 -  Carcinogenesis  Dec 1994 
 - 2859-66 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>0143-3334 
<br/><br/><label>Standard No.: </label>10.1093/carcin/15.12.2859  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Amino Acid Sequence<br/>Animals<br/>Aryl Hydrocarbon Hydroxylases<br/>Bacterial Proteins--genetics<br/>Base Sequence<br/>Biotransformation<br/>CHO Cells<br/>Cell Line<br/>Cricetinae<br/>Cytochrome P-450 CYP2A6<br/>Cytochrome P-450 Enzyme System--genetics<br/>Escherichia coli Proteins<br/>Genes, Reporter--drug effects<br/>Genes, ras<br/>Hypoxanthine Phosphoribosyltransferase--genetics<br/>Mixed Function Oxygenases--genetics<br/>Molecular Sequence Data<br/>Mutagenicity Tests<br/>Nitrosamines--metabolism<br/>Pentosyltransferases<br/>Polymerase Chain Reaction<br/>Proteins<br/>Recombinant Fusion Proteins--genetics<br/>Tetrahydrofolate Dehydrogenase--genetics